Mercury Clinical Research — Houston, Texas

Mercury Clinical Research is a clinical research site located in Houston, Texas, United States 77087.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

Mercury Clinical Research has participated in 13 clinical trials with 2 currently active.

Therapeutic areas: COVID-19, Diabetic Kidney Disease, Acute Migraine.

Sponsors: Novavax, Gilead Sciences, Theranica.

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mercury Clinical Research?

Mercury Clinical Research has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mercury Clinical Research conducted?

Mercury Clinical Research has 13 clinical trials on record, with 2 currently active. Their work covers COVID-19, Diabetic Kidney Disease, Acute Migraine.

Is Mercury Clinical Research accredited by Crixeo Health?

Yes — Mercury Clinical Research holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Mercury Clinical Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.